{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:30:01Z","timestamp":1784590201526,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.02.055","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T13:17:59Z","timestamp":1520083079000},"page":"1921-1924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017"],"prefix":"10.1016","volume":"36","author":[{"given":"Imtiaz","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir A.","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid S.","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfiqar A","family":"Bhutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid B.","family":"Soofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.055_b0005","unstructured":"Cases of Wild Poliovirus by Country and Year. Available at: http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx. [accessed 12\/02\/2018]."},{"key":"10.1016\/j.vaccine.2018.02.055_b0010","unstructured":"Centers for Disease C, Prevention. Apparent global interruption of wild poliovirus type 2 transmission. MMWR Morb Mortal Wkly Rep 2001; 50:222\u20134."},{"key":"10.1016\/j.vaccine.2018.02.055_b0015","unstructured":"Kew OM, Cochi SL, Jafari HS, Wassilak SG, Mast EE, Diop OM, et al. Possible eradication of wild poliovirus type 3\u2013worldwide, 2012. MMWR Morb Mortal Wkly Rep 2014; 63:1031."},{"key":"10.1016\/j.vaccine.2018.02.055_b0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6518a4","article-title":"Progress toward polio eradication \u2013 worldwide, 2015\u20132016","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.02.055_b0025","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.055_b0030","unstructured":"Sheikh MA, Makokha F, Hussein AM, Mohamed G, Mach O, Humayun K, et al. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities \u2013 Kenya, December 2013. MMWR Morb Mortal Wkly Rep 2014; 63:237\u201341."},{"key":"10.1016\/j.vaccine.2018.02.055_b0035","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1097\/INF.0000000000001622","article-title":"Seroprevalence of anti-polio antibodies in children from polio high-risk areas of pakistan: a cross-sectional survey 2015\u20132016","volume":"36","author":"Hussain","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.055_b0040","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jegh.2015.06.004","article-title":"Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014","volume":"5","author":"Gamage","year":"2015","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.vaccine.2018.02.055_b0045","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1016\/j.vaccine.2016.08.058","article-title":"Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria","volume":"34","author":"Iliyasu","year":"2016","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.02.055_b0050","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1093\/infdis\/jiv774","article-title":"Role of serial polio seroprevalence studies in guiding implementation of the polio eradication initiative in Kano, Nigeria: 2011\u20132014","volume":"213","author":"Craig","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.055_b0055","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.vaccine.2013.08.060","article-title":"Survey of poliovirus antibodies in Kano, Northern Nigeria","volume":"32","author":"Iliyasu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.055_b0060","unstructured":"IVB\/WHO. Data, statistics and graphics. Available at: <http:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/en\/>. [accessed 10\/07\/2017]."},{"key":"10.1016\/j.vaccine.2018.02.055_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.02.055_b0070","unstructured":"Polio vaccines: WHO position paper \u2013 March, 2016. Wkly Epidemiol Rec 2016; 91:145-68."},{"key":"10.1016\/j.vaccine.2018.02.055_b0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T17:23:59Z","timestamp":1535045039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":15,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X18302421"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}